Clinical Trial Update: Study of Oral Venetoclax Tablets to Evaluate Adverse Events and Change in Disease Activity in Participants of Any Age With Acute Myeloid Leukemia

View source ↗

Summary

This clinical trial update summarizes the study of oral venetoclax in participants with acute myeloid leukemia, focusing on adverse events and changes in diseas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Venetoclax (venetoclax)

Snippet

Sponsor: AbbVie | Conditions: Acute Myeloid Leukemia (AML) | Status: COMPLETED